Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome.
暂无分享,去创建一个
Smita Y. Patel | Steven M Holland | M. Raffeld | S. Pittaluga | J. Orange | S. Holland | Smita Y Patel | E. Sampaio | A. Hsu | Michelle L. Paulson | D. Vinh | D. Kuhns | G. Uzel | C. Spalding | C. Zerbe | A. Freeman | J. Gea-Banacloche | K. Calvo | J. Lemieux | Mark Raffeld | Douglas B Kuhns | Javed Khan | K. Olivier | David M Frucht | Dennis D Hickstein | Stefania Pittaluga | Amy P Hsu | Gulbu Uzel | Alexandra F Freeman | D. Hickstein | R. Auth | Jordan S Orange | D. M. Frucht | Donald C Vinh | Juan C Gea-Banacloche | Elizabeth P Sampaio | Katherine R Calvo | Jacob E Lemieux | Roger D Auth | Kenneth N Olivier | Christa S Zerbe | Christine Spalding | Li Ding | Michelle L Paulson | Beatriz E Marciano | Jennifer Cuellar-Rodriguez | Beatriz E. Marciano | J. Cuellar-Rodríguez | B. Marciano | J. Khan | L. Ding
[1] A. Dutra,et al. Myelodysplasia in autosomal dominant and sporadic monocytopenia immunodeficiency syndrome: diagnostic features and clinical implications , 2011, Haematologica.
[2] Damien Chaussabel,et al. IRF8 mutations and human dendritic-cell immunodeficiency. , 2011, The New England journal of medicine.
[3] N. McGovern,et al. The human syndrome of dendritic cell, monocyte, B and NK lymphoid deficiency , 2011, The Journal of experimental medicine.
[4] Anna L. Brown,et al. GATA2 is a New Predisposition Gene for Familial Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) , 2010 .
[5] Emery H. Bresnick,et al. GATA Switches as Developmental Drivers* , 2010, The Journal of Biological Chemistry.
[6] P. Bork,et al. A method and server for predicting damaging missense mutations , 2010, Nature Methods.
[7] Adeline R. Whitney,et al. Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia. , 2010, Blood.
[8] D. C. Cabelof,et al. Mutational spectrum at GATA1 provides insights into mutagenesis and leukemogenesis in Down syndrome. , 2009, Blood.
[9] Saijuan Chen,et al. Gain-of-function mutation of GATA-2 in acute myeloid transformation of chronic myeloid leukemia , 2008, Proceedings of the National Academy of Sciences.
[10] Tariq Enver,et al. Haploinsufficiency of GATA-2 perturbs adult hematopoietic stem-cell homeostasis. , 2005, Blood.
[11] S. Holland,et al. Defects in the interferon‐γ and interleukin‐12 pathways , 2005, Immunological reviews.
[12] M. Newport,et al. Clinical features of dominant and recessive interferon γ receptor 1 deficiencies , 2004, The Lancet.
[13] T. Lister,et al. Mutation of CEBPA in familial acute myeloid leukemia. , 2004, The New England journal of medicine.
[14] M. Newport,et al. Clinical features of dominant and recessive interferon gamma receptor 1 deficiencies. , 2004, Lancet.
[15] M. Lasbury,et al. Effect of the Transcription Factor GATA‐2 on Phagocytic Activity of Alveolar Macrophages from Pneumocystis carinii‐Infected Hosts , 2001, Infection and immunity.
[16] Yoshiaki Ito,et al. In vitro analyses of known and novel RUNX1/AML1 mutations in dominant familial platelet disorder with predisposition to acute myelogenous leukemia: implications for mechanisms of pathogenesis. , 2002, Blood.
[17] John M. Maris,et al. Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia , 1999, Nature Genetics.
[18] H. Dietz,et al. Nonsense-mediated mRNA decay in health and disease. , 1999, Human molecular genetics.